Groundbreaking investigative effort identifies gonorrhea vaccine candidates

September 19, 2017, Oregon State University
Credit: CDC

Researchers at Oregon State University have identified a pair of proteins that show promise as the basis for a gonorrhea vaccine.

The findings are an important step toward a potential new weapon in the fight against a that affects millions of people around the globe, with nearly 80 million new cases estimated each year.

The pathogen that causes the disease, Neisseria gonorrhoeae, is considered a "superbug" because of its resistance to all classes of antibiotics available for treating infections.

Gonorrhea is highly damaging to reproductive and neonatal health if untreated or improperly treated. It can lead to endometritis, pelvic inflammatory disease, ectopic pregnancy, epididymitis and infertility. Also, babies born to infected mothers are at increased risk of blindness.

More than half of infected women don't have symptoms, but those asymptomatic cases can still lead to severe consequences for the patient's reproductive health, including miscarriage or premature delivery, said OSU College of Pharmacy researcher Aleksandra Sikora.

Subjecting N. gonorrhoeae to the phenotypic microarray screening method for the first time, Sikora's team focused on seven proteins from the bacteria's cell envelope, which consists of the outer membrane, the cell wall and the inner membrane.

Phenotypic microarrays are a high-throughput system featuring plates with 96 wells per plate, each well representing a different condition under which to research the phenotypes—the observable characteristics—of the examined mutants.

The goal was to see which if any of the seven proteins would show strong potential as a antigen—a molecule that sends the immune system into action. Vaccines prevent disease because the antigens they contain trigger an immune response that allows antibodies to recognize and attack pathogens to prevent future infection.

"Proteins in the cell envelope play key roles in cell function and bacterial physiology," Sikora said. "That and their location make them attractive candidates for developing vaccines. But a lot of them are hypothetical proteins—we know bacteria have them but we don't know for sure how they function. Learning what they contribute to cell structure, permeability, membrane biogenesis and so on is important in vaccine research because antibodies against protein antigens can disable the 's function."

In all, more than 1,000 conditions were used to study the effects of knocking out each of the seven proteins.

"It's like a football coach trying to choose the top quarterback among seven candidates by looking at their performance on many different teams during many different games," Sikora said. "Imagine being able to look at those seven quarterbacks in over a thousand different games simultaneously. Of course, that's not possible with football, but this is what we are doing here to identify the most promising vaccine candidates."

Researchers found 91 conditions that had uniquely positive or negative effects on one of the mutants, and a cluster analysis of 37 commonly beneficial compounds and 57 commonly detrimental compounds revealed three separate phenotype groups.

Two of the proteins, NGO1985 and NGO2121, showed extensive sensitivity to antimicrobial compounds and thus emerged as the most promising vaccine candidates. This study serves as a jumping-off point for further characterization of proteins in the cell envelope.

"Neisseria gonorrhoeae is a difficult bacteria to work with, and it's very diverse," Sikora said. "It has great genome plasticity—there are huge variations between strains. Phenotypic screening allows us to see how similar and how different they are."

Explore further: New gonorrhea treatment targets enzyme needed for respiration

More information: Benjamin I. Baarda et al, Deciphering the Function of New Gonococcal Vaccine Antigens Using Phenotypic Microarrays, Journal of Bacteriology (2017). DOI: 10.1128/JB.00037-17

Related Stories

New gonorrhea treatment targets enzyme needed for respiration

June 26, 2017
Researchers have identified a possible new treatment for gonorrhea, using a peptide that thwarts the infection-causing bacterium by interfering with an enzyme the microbe needs to respirate.

Proteins discovered in gonorrhea may offer new approach to treatment

March 31, 2014
Researchers at Oregon State University have discovered novel proteins in, or on the surface of the bacteria that causes gonorrhea, which offer a promising new avenue of attack against a venereal disease that is showing increased ...

Gonorrhea manipulates an anti-infection mechanism in the female reproductive tract

April 13, 2017
The bacterium that causes gonorrhea infects the female reproductive tract by breaking connections between cells in the tract's protective lining, according to new research published in PLOS Pathogens.

New antibiotic class found effective against gonorrhea in the laboratory

August 7, 2017
The World Health Organisation (WHO) has estimated that 700,000 people around the world die annually from drug resistant infections. It also listed drug resistant gonorrhoea, a sexually transmitted disease caused by the Neisseria ...

Discovery of a Zika antibody offers hope for a vaccine

May 4, 2017
A research team based at The Rockefeller University has identified a potent new weapon against the Zika virus in the blood of people who have been infected by it. This discovery could lead to new ways of fighting the disease, ...

Recommended for you

New long-acting approach for malaria therapy developed

January 22, 2018
A new study, published in Nature Communications, conducted by the University of Liverpool and the Johns Hopkins University School of Medicine highlights a new 'long acting' medicine for the prevention of malaria.

Virus shown to be likely cause of mystery polio-like illness

January 22, 2018
A major review by UNSW researchers has identified strong evidence that a virus called Enterovirus D68 is the cause of a mystery polio-like illness that has paralysed children in the US, Canada and Europe.

Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Flu may be spread just by breathing, new study shows; coughing and sneezing not required

January 18, 2018
It is easier to spread the influenza virus (flu) than previously thought, according to a new University of Maryland-led study released today. People commonly believe that they can catch the flu by exposure to droplets from ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.